Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 52.89
+1.69 (3.30%)
Sep 30, 2026, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 21.02 billion as of October 2, 2026. Its market cap has decreased by -38.32% in one year.
Market Cap
21.02B
Enterprise Value
20.84B
Revenue
4.02B
Ranking
n/a
PE Ratio
20.12
Stock Price
52.89
ChartMarket Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 21.02B, an increase of 46.38%. That is a compound annual growth rate of 5.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 21.02B | -38.46% |
| Dec 31, 2025 | 34.16B | 14.44% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 28.23B |
| Beijing Tiantan Biological Products | 23.97B |
| Hualan Biological Engineering | 23.77B |
| Acrobiosystems | 23.58B |
| Hebei Changshan Biochemical Pharmaceutical | 20.33B |
| Evopoint Biosciences | 18.99B |
| Yili Chuanning Biotechnology | 18.28B |
| HitGen | 17.50B |